ReviewCancer gene therapy2022
PRMT5: a putative oncogene and therapeutic target in prostate cancer.
Elena Beketova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
ReviewCancer gene therapy2022
Elena Beketova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.